Analysis of the Current Situation Johnson and Johnson
Johnson and Johnson are one of the top pharmaceutical manufacturers in the world. The organisation is aimed at providing the pharmaceutical and consumer goods across a range of industries to many of its consumers in the healthcare division. The industry has around 182 marketed drugs in which it leads to drugs to deal with Hepatitis C, HIV/AIDS, arthritis, and digestive conditions. Therefore, the company is superior in the area of medical products to advance to the health of its consumers and the well being of people around the globe.
To analyse the current situation in Johnson and Johnson pharmaceutical industry, I will discuss the SWOT analysis of the industry. To begin with, it is the largest healthcare provider. The industry is operating in three segments, consumer products, medical devices and diagnostics, and Pharmaceuticals. The sector is a family company, and it is committed to ensuring the health of people is stable. Its corporate structure is based on a decentralised management philosophy due to which there are low or no internal management conflict cases that have been reported in the company.
Extensive brand portfolio: the presence of Johnson and Johnson industry within each product categories are strong. The company has a deep assortment and has a large number of brands to choose from which has given them the advantage of occupying large self-space in the store which results in high visibility in the market.
Trusted brand: many of the medical practitioners and parents across the world have trust in the company. The company's primary focus is on tailoring the business to local markets, which have improved them in being relevant to the demands of the consumer.
Strategic merger and acquisition: Johnson and Johnson have created a pool of technological and operational advancement, which helps the company in its further growth. This is through the mergers and acquisition with many consumer health cares and pharmaceutical companies such as Alza and many others.
Supply chain: the company consists the system that is a broad and robust distribution which is meant for making the products available to the consumer, retailers, medical stores and even supermarkets which are readily available for the customers.
Key Opportunities and Threats
Johnson and Johnson is the largest diversified healthcare company in terms of revenues. In the pharmaceutical industry consist of four major external environmental factors which affects the company, it creates opportunities as well as the threat for the company.
Opportunities
The demand for pharmaceuticals in the developed countries and the developing countries is increasing rapidly due to the increase in population in the developing countries. Moreover, there exists a trend of aging in developed countries and adds to the increased number of people with diseases. Thus, this increases the demand for the pharmaceuticals products are never-ending, it connects the lives of all people in the world. With the high demand for the products, it makes the pharmaceuticals and healthcare industries to be stable. Even though the decline of the economy, health care is not affected because people will be willing to pay for their health which means still the demand for pharmaceutical products is high.
The economy is currently retreat may influence Johnson and Johnson organisation, however with such conditions may give chances to the organisation. The organisation can base on the proficient creation, economies of scale or experience impacts to accomplish higher generation productivity, diminish expenses to achieve an upper hand contrasted with the contenders. Likewise, the consistent improvement of innovation in the pharmaceutical business is a noteworthy passage boundary so it can help J&J to keep up its situation in this challenge over the long haul. Then again, organisations can take points of interest in better innovation than set up a distinction for their items.
Threats
Interest for pharmaceuticals is developing so it will make a progressively extreme challenge among pharmaceutical organisations. An ever-increasing number of new infections are hard to treat and cost a ton of cash and time to discover the arrangements. Notwithstanding when J&J put resources into however never discovered or is discovering it yet the cost of items made for utilisation turns out to be troublesome. Particularly when the organisation needs to enter showcases in creating nations. Amid the subsidence of the world, the economy has enormously influenced the advancement organisation J&J. With financial retreat alongside the tempest of value is ascending for nourishment, the requests for pharmaceuticals, particularly for medications sustenance, wellbeing advancement is falling. What's more, the first results of the organisation were sold in the U.S.
Competitive Analysis of the Industry
By investigating Porter's five powers demonstrate, it encourages J&J to discover some more factors that influence the organisation, for example, purchasers, providers, substitutes from that, J&J can create when it is an opportunity and secure itself when it is a risk.
Rivalry Among Existing Firms
The contending among opponents won't make a substantial effect on J&J. Following the explores, 550 organisations have around ten significant organisations. Other than requests of purchasers increment, however, the costs of meds is steady, so there is no much challenge in costs. What's more, the current hindrance is low, so in a similar industry, the organisations watch out for merger or obtaining; the hardware, supplies can be exchanged effectively. Besides, J&J and different organisations enhance their items, they don't pack in just medication, and they can open a separate business.
The Threat of Potential New Entrants
Johnson & Johnson won't be enormously affected by the risk of potential contenders since it is a significant sie organisation with substantial money related, encounters, and so on. The pharmaceutical market in the US is viewed as that has the most elevated hindrance to infiltrate in. Notably, the new contestants into this market may include a few troubles, for example, the costs in examining and advancement, endeavours, encounters, applying the administration's guidelines, and so on the grounds that delivering drug is the troublesome procedure and it requires continued investment with numerous mind-boggling ventures to make the last items.
Bargaining Power of Supplies (Low)
Pharmaceutical, therapeutic gadgets, and diagnostics are results of J&J that needs institutionalisation. As the significant organisation in prescription, picking provider cautiously is essential, and the organisation must have numerous providers; on the off chance that this provider cause deficiency or conveyance late that effect for J&J. Precedent: J&J has 1200 providers, Merch has 160 providers. Besides, it is troublesome for providers to make the expanding an incentive for the items, so making the distinctions among providers is likewise annoying.
The Threat of Substitutes (High)
Core Competencies of Johnson and Johnson
As the pioneer on the rundown of the twelve most prominent pharmaceutical organisations positioned by income, J&J has its very own centre capabilities that the organisation can support well in the focused business these days. To be fruitful, J&J's human asset and brand picture must be esteem, uncommon, defectively incomparable and non-substitutable contrast and different organisations in the same industry.
The Strategic Options
With the pharmaceutical market at an expected $850 billion all-inclusive and expected to develop to more than $1 trillion by 2015, Ms. McCoy and different pioneers will diagram four techniques for development for the organisation's pharmaceuticals business:
Convey separated medications – as of late, the pharmaceuticals business has changed its portfolio by extending its administration in immunology, developed its mastery in oncology and entered immunisations. The organisation's pharmaceuticals organisations are propelling six large new items somewhere in the range of 2009 and 2011, some in various geologies. Two of the new things are pending administrative audit in the European Union (EU), and two other essential mixes are in enrolment in critical markets. A considerable lot of these items could speak to remarkable advances over the present norms of consideration.
Construct transformational pipeline – The pharmaceuticals business' organised interests in interior R&D, vital authorising courses of action, associations, and select acquisitions keep on structure a hearty pipeline as long as possible. The organisation's pharmaceuticals organisations hope to document 11 new items and more than 30 vital line augmentations somewhere in the range of 2011 and 2015.
Reinforce geographic nearness – The pharmaceuticals business will develop its geographic impression and increment interests in emerging markets, assessing market suitable business methodologies and portfolios. It additionally stays concentrated on key created markets. Japan, the second biggest pharmaceuticals showcase, is a crucial development advertise and the organisation's pharmaceuticals organisations have seven dispatches arranged there for 2011. Put resources into gifted individuals and hierarchical capacities – The organisation's pharmaceuticals business is reinforcing initiative abilities locally, provincially and all-inclusive. An essential part includes turning necessary knowledge into critical jobs to rapidly quicken aptitudes improvement to address a developing and complex business condition. The pharmaceuticals business is additionally assembling R&D abilities in innovation territories and developing markets.
Recommendations
For the Johnson and Johnson company to remain the market giant, they should ensure that customers are given the priority as well as their satisfaction. Because of technology is highly growing, then the company needs to use and implement the latest and favorable technologies that will boost the way of reaching customers in various parts and providing the best services. However, the strategy of reinforcing geographic nearness is the best strategy in which it will reduce the distance that customers may cover while looking for the products. This will give the company an advantage over others because their services will be readily available to the customers when they are needed. Choosing the strategy then will see the company prosper and continue providing quality services to the customers.
References
- Barton, J.H., 2004. TRIPS and the global pharmaceutical market. Health Affairs, 23(3), pp.146-154.
- Chandler, A.D., Hikino, T., and Chandler, A.D., 2009. Scale and scope: The dynamics of industrial capitalism. Harvard University Press.
- Cockburn, R., Newton, P.N., Agyarko, E.K., Akunyili, D., and White, N.J., 2005. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS medicine, 2(4), p. e100.
- Cosgrove, L., Krimsky, S., Vijayaraghavan, M. and Schneider, L., 2006. Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychotherapy and Psychosomatics, 75(3), pp.154-160.
- Dunlap‐Hinkler, D., Kotabe, M. and Mudambi, R., 2010. A story of breakthrough versus incremental innovation: Corporate entrepreneurship in the global pharmaceutical industry. Strategic Entrepreneurship Journal, 4(2), pp.106-127.
- Greene, W., 2007. The emergence of India's pharmaceutical industry and implications for the US generic drug market.
- Petryna, A., Lakoff, A. and Kleinman, A. eds., 2006. Global pharmaceuticals. Duke University Press.
